Minneapolis, Minn., October 17, 2005 - ACIST Medical Systems, a clinical and technological company in automated contrast delivery systems and part of the Bracco Group, announced today the introduction of the ACIST CVi Contrast Delivery System for cardiovascular angiographic procedures. This product combines the features of the ACIST CMS and Voyager systems onto one platform.

The ACIST CVi, highlighted at the Transcatheter Cardiovascular Therapeutics (TCT) symposium in Washington, D.C., is expected to be commercially available in the first quarter of 2006, or before. "The new CVi combines enhanced ease of use with the reliability and flexibility that clinicians have come to expect from ACIST," states Fulvio Renoldi Bracco, Chairman of ACIST. "Preliminary customer feedback has been excellent, and I am confident that the ACIST CVi will further enhance both workflow and productivity in the angiographic suite."

ACIST implements innovation by developing systems that can be set up to meet the unique needs of the patient, the clinicians and the requirements of each procedure. This fourth generation product enhances the ease of contrast and saline injection for physicians, nurses and technicians with the following new system benefits: ease and simplicity, procedural flexibility and workflow, versatility of equipment setup, precision and control, trust and reliability, and cost effectiveness and enhanced workflow, according to the company.
With over 800,000 procedures annually, and growing, ACIST is a leading player in precision, user-controlled, variable-rate delivery of contrast media for both large and small vessel angiography. Since the system's introduction in 1998, numerous articles in top tier interventional cardiology journals have described its potential benefits.

More Voices